Plant-derived molecules as multitarget modulators of NF-κB, PI3K/Akt, MAPK, and AMPK/mTOR signaling in chronic

Kaushik Modak1, Arup Dey1, Krishna Kumar Bharti1

  • 1Faculty of Pharmaceutical Science, Assam down town University, Sankar Madhab Path, Gandhi Nagar, Panikhaiti, Guwahati, Assam, 781026, India.

Insights

Plant phytochemicals can modulate key cell signaling pathways to combat chronic diseases like cancer and diabetes. This review integrates evidence on how these natural compounds restore cellular balance and offers insights into their therapeutic potential.

Area of Science:

  • Cellular Biology
  • Pharmacology
  • Biochemistry

Background:

  • Cell signaling pathways (e.g., NF-κB, MAPK, PI3K/Akt) are crucial for cellular functions but their dysregulation drives chronic diseases.
  • Interconnected signaling networks are implicated in cancer, diabetes, cardiovascular, neurodegenerative, and inflammatory conditions.

Purpose of the Study:

  • To provide an integrated overview of how plant-derived phytochemicals modulate major signaling pathways involved in chronic diseases.
  • To emphasize the mechanistic cross-talk and translational relevance of phytochemical actions.

Main Methods:

  • A comprehensive literature survey was conducted using PubMed, SciFinder, and Google Scholar.
  • Experimental and clinical evidence on phytochemical regulation of signaling pathways was collected and analyzed.

Main Results:

  • Major phytochemicals (curcumin, resveratrol, quercetin, etc.) suppress pro-inflammatory and pro-cancer pathways (NF-κB, PI3K/Akt, MAPK, JAK/STAT).
  • These compounds activate protective pathways like Nrf2-mediated antioxidant defense, AMPK signaling, autophagy, and apoptosis.
  • Phytochemicals regulate metabolic inflammation, neuroinflammation, mitochondrial dysfunction, and cancer signaling.

Conclusions:

  • Phytochemicals act as multitarget modulators, restoring signaling balance across diverse chronic diseases.
  • Despite therapeutic promise, clinical translation is hindered by bioavailability, pharmacokinetics, standardization, and validation challenges.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...